NoulLtd (KOSDAQ:A376930) - Stock Price, News & Analysis

A376930 Stock Overview

Engages in the in vitro diagnosis and remote diagnosis business worldwide.

A376930 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Risk Analysis

Highly volatile share price over the past 3 months compared to the KR market

Has less than 1 year of cash runway

Earnings have declined by 19.6% per year over past 5 years

Does not have a meaningful market cap (₩103B)

+ 1 more risk

Noul Co.,Ltd. Competitors

Hironic

KOSDAQ:A149980

₩109.0b

DENTISLtd

KOSDAQ:A261200

₩106.6b

Ray

KOSDAQ:A228670

₩127.1b

Solborn

KOSDAQ:A035610

₩101.8b

Price History & Performance

Summary of all time highs, changes and price drops for NoulLtd
Historical stock prices
Current Share Price	₩2,635.00
52 Week High	₩6,660.00
52 Week Low	₩1,820.00
Beta	-0.64
11 Month Change	-12.89%
3 Month Change	6.25%
1 Year Change	-50.93%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-42.78%

Recent updates

Shareholder Returns

	A376930	KR Medical Equipment	KR Market
7D	-16.5%	-1.9%	-1.0%
1Y	-50.9%	12.3%	3.2%

Return vs Industry: A376930 underperformed the KR Medical Equipment industry which returned 12.3% over the past year.

Return vs Market: A376930 underperformed the KR Market which returned 3.2% over the past year.

Price Volatility

Is A376930's price volatile compared to industry and market?
A376930 volatility
A376930 Average Weekly Movement	16.0%
Medical Equipment Industry Average Movement	7.0%
Market Average Movement	5.5%
10% most volatile stocks in KR Market	11.6%
10% least volatile stocks in KR Market	2.6%

Stable Share Price: A376930's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A376930's weekly volatility has increased from 11% to 16% over the past year.

About the Company

Founded	Employees	CEO	Website
2015	139	David Lim	www.noul.kr

Noul Co.,Ltd. engages in the in vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis.

Noul Co.,Ltd. Fundamentals Summary

How do NoulLtd's earnings and revenue compare to its market cap?
A376930 fundamental statistics
Market cap	₩102.71b
Earnings (TTM)	-₩20.59b
Revenue (TTM)	₩1.42b

68.6x

P/S Ratio

-4.7x

P/E Ratio

Is A376930 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A376930 income statement (TTM)
Revenue	₩1.42b
Cost of Revenue	₩1.43b
Gross Profit	-₩8.47m
Other Expenses	₩20.59b
Earnings	-₩20.59b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-557.40
Gross Margin	-0.60%
Net Profit Margin	-1,450.60%
Debt/Equity Ratio	3.8%

How did A376930 perform over the long term?

See historical performance and comparison

NoulLtd KOSDAQ:A376930 Stock Report